Scarica l'app Stockscreener
15.59
0.04%
-0.0108
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Storia dei dividendi
Organon Co Borsa (OGN) Ultime notizie
Organon & Co. (OGN) is Attracting Investor Attention: Here is What You Should Know - Yahoo Finance
Organon (OGN): Company Profile, Stock Price, News, Rankings - Fortune
Organon (OGN) Advances While Market Declines: Some Information for Investors - MSN
Why Organon Is A Top Pick For Income Investors (NYSE:OGN) - Seeking Alpha
Is Organon & Co. (OGN) the Deep Value Stock to Buy Now? - Insider Monkey
Organon & Co. (NYSE:OGN) Receives $20.80 Consensus Target Price from Analysts - Defense World
Organon & Co. (NYSE:OGN) Shares Sold by US Bancorp DE - Defense World
Organon & Co (OGN) Trading Down 2.88% on Mar 12 - GuruFocus.com
Organon’s SWOT analysis: stock poised for growth amid challenges By Investing.com - Investing.com Australia
Organon’s SWOT analysis: stock poised for growth amid challenges - Investing.com India
Trend Tracker for (OGN) - Stock Traders Daily
Proficio Capital Partners LLC Acquires New Holdings in Organon & Co. (NYSE:OGN) - Defense World
Healthcare Veteran Appointed CEO of May Health's Groundbreaking PCOS Technology - StockTitan
New Analysis of Organon’s VTAMA® (tapinarof) cream, 1% Phase 3 Data Shows Atopic Dermatitis Disease Activity Remained Low After Treatment-Free Interval in Adults and Children 2 Years of Age and Older - BioSpace
MAY HEALTH APPOINTS SEASONED MEDTECH EXECUTIVE, COLBY HOLTSHOUSE, AS PRESIDENT AND CEO - Quantisnow
Organon announes results from analysis of Phase 3 ADORING 3 study - TipRanks
Can This Skin Treatment Work for Months After Stopping? New Clinical Data Reveals Surprising Results - StockTitan
Organon and Partners Advance Women’s Health Innovation to Drive Economic and Social Growth in Southeast Asia - The Hastings Tribune
Organon and partners drive innovation to strengthen healthcare access - Bangkok Post
Organon & Co. (NYSE:OGN) Shares Sold by Private Advisor Group LLC - Defense World
Truist Financial Corp Increases Stock Holdings in Organon & Co. (NYSE:OGN) - Defense World
(OGN) Long Term Investment Analysis - Stock Traders Daily
Principal Financial Group Inc. Raises Stock Position in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Common Retirement Fund Buys 43,928 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon & Co. (NYSE:OGN) Shares Up 5.7%Here's What Happened - MarketBeat
A&I Financial Services LLC Invests $402,000 in Organon & Co. (NYSE:OGN) - MarketBeat
Is Organon & Co. (OGN) the Best Low Price Pharma Stock to Invest In Right Now? - Insider Monkey
Rhumbline Advisers Sells 14,051 Shares of Organon & Co. (NYSE:OGN) - Defense World
Principal Financial Group Inc. Buys 32,485 Shares of Organon & Co. (NYSE:OGN) - Defense World
The Hidden Gems of the Pharma World: Stocks Analysts Can’t Ignore - jomfruland.net
Organon & Co. (OGN): Among the Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
10 Cheap Pharmaceutical Stocks to Buy According to Analysts - Insider Monkey
Allspring Global Investments Holdings LLC Increases Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
New York State Teachers Retirement System Has $4.61 Million Holdings in Organon & Co. (NYSE:OGN) - Defense World
Savant Capital LLC Sells 88,315 Shares of Organon & Co. (NYSE:OGN) - MarketBeat
Organon's SWOT analysis: women's health leader faces biosimilar growth, LOE challenges - MSN
Organon announces departure of chief commercial officer - MSN
Philip James Wealth Mangement LLC Has $12.99 Million Holdings in Organon & Co. (NYSE:OGN) - MarketBeat
1.99%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):